THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Article questions Eli Lilly marketing push

NIH team: Firm aimed to shape drug guidelines

By Diedtra Henderson
Globe Staff / October 19, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Eli Lilly and Co. funded medical guidelines created for the treatment of a deadly infection in an effort to boost sales of a drug with questionable benefits, according to an article in today's issue of the New England Journal of Medicine . (Full article: 558 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass